[Federal Register Volume 62, Number 73 (Wednesday, April 16, 1997)]
[Notices]
[Page 18632]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-9902]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Vaccine Advisory Committee (NVAC), Subcommittee on
Vaccine Safety, Subcommittee on Immunization Coverage, Subcommittee on
Future Vaccines, and the Advisory Commission on Childhood Vaccines
(ACCV) Subcommittee on Vaccine Safety: Meetings
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following Federal advisory committee
meetings.
Name: National Vaccine Advisory Committee (NVAC).
Times and dates: 8:45 a.m.-12:15 p.m., May 1, 1997. 8:30 a.m.-
1:15 p.m., May 2, 1997.
Place: Hubert H. Humphrey Building, Room 703A, 200 Independence
Avenue, SW, Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Notice: In the interest of security, the Department has
instituted stringent procedures for entrance to the Hubert H.
Humphrey Building by non-government employees. Thus, persons without
a government identification card should plan to arrive at the
building each day either between 8 and 8:30 a.m. or 12:30 and 1 p.m.
so they can be escorted to the meeting. Entrance to the meeting at
other times during the day cannot be assured.
Purpose: This committee advises and makes recommendations to the
Director of the National Vaccine Program on matters related to the
Program responsibilities.
Matters to be discussed: Agenda items will include a National
Vaccine Program Office (NVPO) update; a discussion on review of the
Department of Health and Human Services' Adult Immunization Plan; a
discussion on the survey on practices of non-traditional providers;
a report of meeting on simian-virus-40--next steps; AIDS vaccine,
the progress in vaccine development and organizational approach; the
national vaccine plan focusing on priorities; tuberculosis vaccines,
barriers and opportunites; the National Institutes of Health (NIH)
will discuss their program on tuberculosis and vaccine options;
discussion from the Advisory Council on the Elimination of
Tuberculosis; improving immunization coverage report from the Sabin
Foundation; report from the Subcommittee on Immunization Coverage;
report from the Subcommittee on Future Vaccines; report from the
Subcommittee on Vaccine Safety; and status of the Work Group on
philosophical exemptions.
Agenda items are subject to change as priorities dictate.
Name: Subcommittee on Vaccine Safety and the Advisory Commission
on Childhood Vaccines, Subcommittee on Vaccine Safety.
Time and date: 1:15 p.m.-5 p.m., May 1, 1997.
Place: Hubert H. Humphrey Building, Room 425A, 200 Independence
Avenue, SW, Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Purpose: This joint NVAC/ACCV subcommittee will review issues
relevant to vaccine safety and adverse reactions to vaccines.
Matters to be discussed: This subcommittee will discuss the
update on the Public Health Service vaccine safety activities;
vaccine safety surveillance overview; vaccine safety funding; and
agenda items for next meeting.
Name: Subcommittee on Immunization Coverage.
Time and date: 1:15 p.m.-5 p.m., May 1, 1997.
Place: Hubert H. Humphrey Building, Room 423A, 200 Independence
Avenue, SW, Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Purpose: This subcommittee will identify and propose solutions
that provide a multifaceted and holistic approach to reducing
barriers that result in low immunization coverage for children.
Matters to be discussed: This subcommittee will discuss the
review of recommendations from the document ``Strategies to Sustain
Immunization Coverage'; and a discussion and finalization of the
recommendations.
Name: Subcommittee on Future Vaccines.
Time and date: 1:15 p.m.-5 p.m., May 1, 1997.
Place: Hubert H. Humphrey Building, Room 405A, 200 Independence
Avenue, SW, Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Purpose: The Subcommittee on Future Vaccines will develop policy
options and guide national activities which will lead to accelerated
development, licensure, and best use of new vaccines in the simplest
possible immunization schedules.
Matters to be discussed: This subcommittee will discuss an
update on vaccine procurement strategies and case studies in vaccine
development.
Contact person for more information: Felecia D. Pearson,
Committee Management Specialist, NVPO, CDC, 1600 Clifton Road, NE,
M/S D50, Atlanta, Georgia 30333, telephone 404/639-7250.
Dated: April 11, 1997.
John C. Burckhardt,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention (CDC).
[FR Doc. 97-9902 Filed 4-15-97; 8:45 am]
BILLING CODE 4163-18-P
